Oliver Schmidt Email & Phone Number

Indianapolis, Indiana, Us

Indianapolis, Indiana, Us

Leads early phase (exploratory) drug development and clinical pharmacology organization. Therapeutic areas:NeuroscienceDiabetes and CVAutoimmune Diseases

Indianapolis, Indiana, Us

Durham, North Carolina, Us

General Manager and Strategy Lead of Translational Drug Research UnitHead of Unit Executive Leadership TeamImplementation and oversight of all operational processes, including:- Safety and well-being of healthy volunteers and patients- Performance of high quality translational studies- Finance, Quality Assurance and HR support functionsDevelopment and maintenance of partnerships with key customersCollaboration with and participation in business development functionLeadership of initiatives in standard setting for Quality policies and proceduresIntegration of Unit with other company business units and Quintiles Centers of Excellence

Tokyo, Jp

Project leader, heading interdisciplinary teams of clinicians, pharmacists and scientists, responsible for:- Design of clinical development strategies- Planning and execution of early and late trials- Exploration of asset maximization strategyAdviser on corporate strategy in respiratory medicineMedical lead and accountability for programs in various disease areas including:- Infant Respiratory Distress Syndrome- Idiopathic Pulmonary Fibrosis- Psoriasis

Basel, Baselstadt, Ch

Project Leader, managing a team of 12 scientists responsible for respiratory drug development projects ranging from Candidate selection to Proof-of-ConceptClinical Pharmacology expert, leading compound profiling of late-phase projectsSpecialty Area: Pulmonary Hypertension Submission of compound targeting Pulmonary Arterial Hypertension for Market Authorization (NDA/MAA) Organizer and moderator of 2 day workshop and advisory board meeting on novel biomarkers and technologies for use in clinical trials investigating the efficacy of drugs in Pulmonary Arterial HypertensionMember of internal respiratory biomarker groupTranslational Medicine Representative on 2 Global Product TeamsMedical Lead and overall accountability for:Proof-of-Concept study investigating the effects of a novel compound targeting acute exacerbations in COPDADME (mass balance) study of a novel compound targeting acute exacerbations in COPDProof-of-Concept study investigating the effects of nilotinib in patients with Pulmonary Arterial HypertensionProof-of-Concept extension study investigating the long-term safety and effect on 6 minute-walking distance of imatinib in patients suffering from Pulmonary Arterial HypertensionPharmacokinetic study investigating the drug-drug interactions between imatinib, bosentan Member of ABPI Experimental Medicine Expert NetworkEditor of 2012 ABPI Phase 1 Guidelines

Cambridge, Cambridgeshire, Gb

Medical Lead for respiratory (early phase) drug development projects ranging from lead optimisation to Phase IIbDisease Area Medical Lead for methodological exploration of COPD co-morbiditiesMedical Advisor for late phase in-licensing projectMember of ABPI Experimental Medicine Expert Network

Suresnes, Fr

Research Physician in metabolic disease area responsible for planning and inception of late phase project developmentSupervision of International Study Managers

Successful milestone transition of several respiratory projectsSuccessful introduction of novel 3-in-1 FTiM study design cutting 6 months out of development timeframePrinciple Investigator in approximately 150 clinical trials ranging from classic Clinical Pharmacology to PoX studies as well as specialized compound and formulation performance studies.Extensive experience in the development of oral and inhaled compounds targeting diseases of the respiratory system (i.e. asthma, COPD, cystic fibrosis).Hands-on experience in wide range of concepts and technologies, amongst others.:• Whole Body Plethysmography and Spirometry• Oscillometry• Pulmonary drug distribution and deposition• Mucociliary clearance• Mass balance• Microdosing• Glucose Clamp• Neuropathic Pain Model• Scintigraphic gastric emptying, GI transit and absorption studies.

Medical Lead/Investigator responsible for supervision and conduct of Early Phase Clinical Trials with particular focus in neuroscience and respiratory disease areasSupervision of study nurses and trial technicians

Edinburgh, Gb

St Andrews, Fife, Gb

St Andrews, Fife, Gb

Abdominal & Orthopaedic Surgery, Accident & Emergency

Phd, Developmental Neurobiology

Md, Medicine

Md, Medicine